Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,050 | 2,940 | 2,640 | 3,810 | 9,650 |
| Marketable Securities | 22,460 | 17,350 | 18,110 | 12,020 | 0 |
| Receivables | 60 | 60 | 60 | 250 | 40 |
| Other current assets | 580 | 130 | 160 | 180 | 110 |
| TOTAL | $26,150 | $20,480 | $20,970 | $16,260 | $9,800 |
| Non-Current Assets | |||||
| Investments And Advances | 20 | 20 | 110 | 290 | 210 |
| TOTAL | $20 | $20 | $110 | $290 | $210 |
| Total Assets | $31,220 | $25,430 | $26,050 | $21,530 | $13,470 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 910 | 1,990 | 880 | 860 | 470 |
| TOTAL | $910 | $1,990 | $880 | $860 | $470 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 0 | 100 |
| Other Non-Current Liabilities | 150 | 150 | 150 | 150 | 0 |
| TOTAL | $150 | $150 | $150 | $150 | $100 |
| Total Liabilities | $1,060 | $2,140 | $1,030 | $1,010 | $580 |
| Shareholders' Equity | |||||
| Common Shares | 54,290 | 45,760 | 44,710 | 40,610 | 26,280 |
| Retained earnings | -30,860 | -27,670 | -24,990 | -23,290 | -15,400 |
| Other shareholders' equity | 2,290 | 1,500 | 1,600 | 0 | -10 |
| TOTAL | $30,150 | $23,290 | $25,010 | $20,520 | $12,880 |
| Total Liabilities And Equity | $31,210 | $25,430 | $26,040 | $21,530 | $13,460 |